内皮生物标志物与脓毒症相关儿童急性呼吸窘迫综合征的间接肺损伤相关
该观察性队列研究纳入学术型PICU中<18岁脓毒症相关ARDS患儿,直接肺损伤(肺炎,n=52)与间接肺损伤(肺外脓毒症,n=46)各一组。在58种血浆生物标志物中,33种在两种亚型间存在差异;分类回归树模型显示,仅用四种内皮生物标志物(Ang-2/Ang-1比值升高、VCAM、vWF等)识别间接ARDS的敏感性89%(80-97%)、特异性80%(69-92%)、PPV 84%(74-93%)、NPV 86%(76-96%),优于仅用临床变量的模型。提示间接肺损伤以内皮激活、过度炎症和更差结局为特征,该模型有潜力精准识别可能受益于内皮靶向治疗的患者。
要点
- 在脓毒症相关儿童ARDS中,间接肺损伤(肺外脓毒症)与内皮激活生物标志物谱相关,直接肺损伤(肺炎)则不然。
- 四种内皮生物标志物模型识别间接ARDS:敏感性89%(80-97%)、特异性80%(69-92%)、PPV 84%(74-93%)、NPV 86%(76-96%)。
- 58种生物标志物中33种在直接与间接ARDS亚型间存在差异,提示两种亚型病理生物学不同。
- 仅用临床变量(年龄、性别、种族、肿瘤合并症、PRISM-III评分)的模型表现差于加入生物标志物的模型。
- 该模型目前仅具研究潜力,尚不能作为床旁常规决策工具,需未来试验验证。
适用人群与场景
- 学术型PICU中<18岁脓毒症相关ARDS患儿;直接肺损伤组为肺炎(n=52),间接肺损伤组为肺外脓毒症(n=46)。
诊断标准与关键阈值
- 原文未提及脓毒症或ARDS的具体诊断标准及评分界值。
- 分类回归树模型使用四种内皮生物标志物(Ang-2/Ang-1比值升高、VCAM、vWF等)识别间接ARDS,但原文未给出各标志物的具体阈值。
处置流程与药物剂量
- 原文未提及针对该生物标志物模型的具体处置流程或药物剂量。
- 原文提及内皮靶向治疗为未来试验方向,未给出具体药物、剂量或方案。
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的红旗征。
研究设计与关键结果
- 58种血浆生物标志物中33种在直接与间接ARDS亚型间存在差异。
- 仅用临床变量(年龄、性别、种族、肿瘤合并症、PRISM-III评分)的分类回归树模型表现差于加入58种生物标志物的模型。
- 最佳分类回归树模型仅用四种内皮生物标志物(Ang-2/Ang-1比值升高、VCAM、vWF等)识别间接ARDS:敏感性89%(80-97%)、特异性80%(69-92%)、PPV 84%(74-93%)、NPV 86%(76-96%)。
- 间接肺损伤生物标志物谱提示内皮激活、过度炎症和更差结局。
证据类型、等级与局限
- 证据类型:单中心观察性队列研究。
对床旁实践的改变
- 该研究提示脓毒症相关儿童ARDS的间接肺损伤亚型具有内皮激活特征,可能为未来内皮靶向治疗试验提供患者选择依据。
- 当前四种内皮生物标志物模型尚不能常规用于床旁区分直接与间接ARDS,原文结论为「有潜力」而非推荐。
- 临床变量模型表现较差,提示仅凭临床特征区分ARDS亚型可能不够精确。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute respiratory distress syndrome occurring in the setting of direct versus indirect lung injury may reflect different pathobiologies amenable to different treatment strategies. We sought to test whether a panel of plasma biomarkers differed between children with sepsis-associated direct versus indirect acute respiratory distress syndrome. We hypothesized that a biomarker profile indicative of endothelial activation would be associated with indirect acute respiratory distress syndrome.
DESIGN: Observational cohort.
SETTING: Academic PICU.
SUBJECTS: Patients less than 18 years old with sepsis-associated direct (pneumonia, n = 52) or indirect (extrapulmonary sepsis, n = 46) acute respiratory distress syndrome.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 58 biomarkers examined, 33 differed by acute respiratory distress syndrome subtype. We used classification and regression tree methodology to examine associations between clinical and biochemical markers and acute respiratory distress syndrome subtype. The classification and regression tree model using only clinical variables (age, sex, race, oncologic comorbidity, and Pediatric Risk of Mortality-III score) performed worse than the classification and regression tree model using five clinical variables and 58 biomarkers. The best classification and regression tree model used only four endothelial biomarkers, including elevated angiopoietin-2/angiopoietin-1 ratio, vascular cell-adhesion molecule, and von Willebrand factor, to identify indirect acute respiratory distress syndrome. Test characteristics were 89% (80-97%) sensitivity, 80% (69-92%) specificity, positive predictive value 84% (74-93%), and negative predictive value 86% (76-96%).
CONCLUSIONS: Indirect lung injury in children with acute respiratory distress syndrome is characterized by a biomarker profile indicative of endothelial activation, excess inflammation, and worse outcomes. A model using four biomarkers has the potential to be useful for more precisely identifying patients with acute respiratory distress syndrome whose pathobiology may respond to endothelial-targeted therapies in future trials.
参考来源
- Whitney JE, Feng R, Koterba N, et al. Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress Syndrome. Crit Care Explor. 2020. PMID: 33299985. doi:10.1097/CCE.0000000000000295
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。